US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 7.080
  • +0.110+1.58%
Close Jan 17 16:00 ET
  • 7.300
  • +0.220+3.10%
Post 20:01 ET
433.11MMarket Cap-1.27P/E (TTM)

Sage Therapeutics Key Stats

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 15.726M--
--2024/Q4-- / 14.111M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 15.726M--
--2024/Q4-- / 14.111M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 17, 2025

Hold

  • Buy

    17.65%
  • Hold

    70.59%
  • Sell

    11.77%

Price Target

No Data